9 min read

The GenAI Divide: Beyond the 95% Failure Myth and the Workslop Epidemic

MIT revealed 95% of enterprises gain no ROI from GenAI—a headline that fuels skepticism but masks the deeper truth: the GenAI Divide. A small 5% capture massive value, while most drown in stalled pilots and workslop. Success hinges not on hype, but on governance and strategy.
The GenAI Divide: Beyond the 95% Failure Myth and the Workslop Epidemic

This post is for paying subscribers only